Immunofluorescence Assay (IFA) Market Overview, Size, Share and Demand 2028Posted by RakshaGajbhiye on May 11th, 2021 The global immunofluorescence assay (IFA) market size is expected to reach USD 4.01 billion by 2028 at a CAGR of 6.3%, according to the latest report by Reports and Data. Increasing global healthcare burden of chronic and infectious diseases, rising application of immunofluorescence assays in clinical diagnostics and research, and growing investments and expenditure in healthcare sector are key factors expected to drive market revenue growth over the forecast period. Immunofluorescence assay is a microscopic technique primarily used on microbiological samples, which uses the specificity of antibodies to their antigens. Antibodies are labelled with fluorescent dye and the subsequently formed antigen-antibody complex can be visualized using fluorescent microscope. Immunofluorescence assays are of two types: direct immunofluorescence, which uses primary antibody that is conjugated to fluorescent dye and indirect immunofluorescence in which a secondary antibody is conjugated with fluorophore against a primary antibody that is used for detection. IFA is a standardized technique extensively used in virology to determine the presence of antibodies by their specificity to viral antigens that are expressed by the infected cells. Immunofluorescence assays have also been used to develop antibodies against SARS-CoV-2 to enable efficient detection and curb the spread of the virus, and this trend is expected to continue going ahead. Development of advanced medical facilities, increasing biopharmaceutical R&D, rising focus on antibody-based therapies, and increasing number of preclinical and clinical research studies globally are some of the key factors expected to drive market growth over the forecast period. However, lack of skilled professionals and techniques and high costs of assays are expected to hamper market growth to a certain extent over the forecast period. Prominent companies in the market include Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Abcam Plc, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Werfen Company, Agilent Technologies, Cell Signaling Technology, Inc., MEDIPAN GmbH, Enzo Biochem, Inc., Becton, Dickinson and Company, Bruker Corporation, and EpiGentek Group, and others. Product Outlook (Revenue, USD Billion; 2018-2028)
Type Outlook (Revenue, USD Billion; 2018-2028)
Disease Outlook (Revenue, USD Billion; 2018-2028)
End-use Industry Outlook (Revenue, USD Billion; 2018-2028)
Regional Outlook (Revenue, USD Billion; 2018-2028)
Some Key Highlights From the Report:
Thank you for reading our report. To inquire about customization options or for any queries about the report, please get in touch with us. Our team will make sure the report is best suited to your needs. Like it? Share it!More by this author |